Thu, Jun 13, 2024
Torrent Pharmaceuticals said on Wednesday that its that it Indrad, Gujarat-based manufacturing facility had received Form 483 from the US FDA. The pharma firm said that the US FDA had conducted a pre-approval inspection (PAI) and a GMP inspection at the its manufacturing facility in Indrad, Gujarat, from June 3 to June 12.
More >
Mon, May 27, 2024
Results Review : Divi's Laboratories, Torrent Pharma, Aurobindo Pharma, Glenmark Pharma, United Spirits, Hindalco, Ashok Leyland और NTPC के नतीजे कैसे रहे? नतीजों के बाद किन शेयरों में करें खरीदारी? जानिए एनालिसिस Anil Singhvi से.
Torrent Pharma Q4 results: Torrent Pharmaceuticals shares jumped nearly seven per cent on Monday, May 27 after the pharma company reported a strong set of March quarter results.
Fri, May 24, 2024
Torrent Pharma (TORNTPHARM) Q4 Results Preview, Market News: Ahmedabad-based Torrent Pharma is estimated to register a 56 per cent year-on-year jump in consolidated net profit to Rs 447 crore for the March quarter, according to Zee Business research. Read on to know what else you can expect.
Sun, May 05, 2024
Brokerage Axis Securities recommends buying stocks for two weeks. These include Orient Electric, Coal India, JSW Energy among others.
Fri, Feb 02, 2024
Torrent Pharma Q3 Results: Torrent Pharmaceuticals reported a 52 per cent increase in its consolidated profit after tax to Rs 443 crore for the third quarter ended December 2023.
Wed, Oct 25, 2023
Operating EBITDA during the period came in at Rs 825 crore, up 22 per cent YoY. In the Q2 period of the previous fiscal, operation profitability was at Rs 679 crore.
Mon, Oct 23, 2023
Torrent Pharma Q2 results: Its net profit in July-September at Rs 386 crore was 23.7 per cent higher than Rs 312 crore net earning in the same period a year back, the company said in a statement. Revenues soared 16 per cent to Rs 2,660 crore.
Thu, Sep 14, 2023
Cipla से जुड़ी Big news related to Cipla: Bids to buy promoters' shares will start soon, bids to buy shares possible by the third week of this month.
Thu, Aug 24, 2023
The Establishment Inspection Report (EIR) was received after the inspection was conducted at the Dahej facility by USFDA between May 17 and May 25, 2023, Torrent Pharma said in a filing to the stock exchanges.
Mon, Aug 21, 2023
Big news for Cipla and TorrentPharma! Can Cipla promoters sell stake? Know full details in this video
Wed, May 31, 2023
Torrent Pharma shares surged to a 52-week high on Wednesday, a day after the drug maker reported a quarterly net profit as against a net loss for the corresponding period a year ago.
Tue, May 30, 2023
Torrent Pharma reported a net profit of Rs 287 crore for the quarter ended March 2023. The board of the Gujarat-based pharma company recommended a dividend of Rs 8 per share, subject to shareholders' approval.
Thu, Mar 23, 2023
Stocks to buy today: In conversation with Zee Business Managing Editor Anil Singhvi, market experts Rakesh Bansal, Sumeet Bagadia, Kunal Saraogi, Himanshu Gupta and Vikas Sethi share their top recommendations for the March 23 session.
Wed, Jan 11, 2023
Jefferies and HSBC have recommended, Cipla, Sun Pharma, Divi's Laboratories, Biocon, Lupin and others
Fri, Sep 30, 2022
global brokerage are bullish on these stocks for investors to take decision and may add these in their portfolio. In this video here you know the full list
Wed, Sep 28, 2022
Torrent Pharma on Tuesday through a regulatory filing said that it will acquire Curatio Healthcare for Rs 2,000 crore to strengthen its presence in the dermatology segment.
Torrent Pharma buys Curatio Health. Acquisition done for ₹2000 crore. GOOD or BAD Deal for Torrent Pharma? What is the opinion of brokerages on the deal? Know full details from Nupur.
Tue, Sep 27, 2022
Torrent Pharmaceuticals on Tuesday said it will acquire Curatio Healthcare for Rs 2,000 crore to strengthen its presence in the dermatology segment.
Mon, Aug 01, 2022
Pharmaceutical companies’ stocks such as Cipla, Zydus Wellness, and Torrent Pharma rose up to 5% on the BSE intraday trade.
Despite healthy Q1FY23 earnings, the pharma major Sun Pharma shares were seen trading flat in the early morning and later declined more than 3 per cent to Rs 913 per share on the BSE intraday on Monday.
Thu, Jul 07, 2022
The brokerage house has advised investors to buy on these stocks. According to the brokerage, this stock can give a return of about 27% from here.
Fri, May 27, 2022
Snapping three day-losing streaks, the Indian market ended higher by nearly one per cent on monthly derivatives expiry day on Thursday.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
